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Abstract
Background: The aim of this study was to investigate sex differences and associations of high molecular weight (HMW)
adiponectin, leptin and proinflammatory adipokines, individually or in combinations, with adiposity and insulin resistance
(IR) measures in prepubertal childhood.
Methodology: We studied 305 prepubertal children (boys/girls: 144/161; Tanner stage 1; age: 5-13 yr), included in a cohort
of 44,231 adolescents who participated in an extensive Italian school-based survey. According to Cole’s criteria, 105
individuals were lean (L; boys/girls: 59/46), 60 overweight (OW; boys/girls: 32/28) and 140 obese (OB; boys/girls: 70/70).
Measurements comprised total and HMW adiponectin, leptin, as well as a panel of proinflammatory adipokines/chemokines
associated with diabetes risk.
Principal Findings: Leptin-, and the leptin-to-HMW adiponectin ratio (L/HMW)-, increased progressively (p,0.0001) from L
to OW to OB boys and girls. When compared with L peers, OW and OB girls exhibited lower (p,0.001) HMW adiponectin
levels, while in boys the HMW multimers did not differ significantly across the BMI-stratified groups. OB girls displayed
higher (p,0.05) IL-8, IL-18, monocyte chemoattractant protein-1 (MCP-1) and soluble intercellular adhesion molecule-1
levels (sICAM-1) than L girls, whereas increased macrophage migration inhibitory factor (MIF) concentrations in OB vs OW
boys were seen. HMW adiponectin (negatively), leptin or inflammatory markers (positively) correlated with adiposity and IR
measures. In multivariate models, leptin represented a strong and independent determinant of HOMA-IR (R
2 0.378; p,0.01).
Adjustment for age, BMIz-score, lipids and inflammatory mediators abolished the association between leptin and HOMA-IR in
boys, while in girls leptin remained still a significant predictor of IR (R
2 0.513; p,0.01). Finally, in both sexes, the joint effect
of the L/HMW did not improve the prediction of basal IR as compared with leptin levels alone, which were mainly explained
by the BMIz-score.
Conclusions: In prepubertal children, leptin emerges as a sex-independent discrimination marker of adiposity degree and as
a useful, sex-associated predictor of the systemic insulin resistance.
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Introduction
Accumulating evidence indicates that chronic low-grade
inflammation independently predicts the development of type 2
diabetes (T2D) and coronary heart disease (CHD) [1]. The
emerging role of adipose tissue as a bioactive endocrine organ
secreting an ever increasing number of mediators, collectively
known as adipokines, supports the concept that fat tissue per se is a
strong determinant of systemic inflammation and a culprit
underlying both the insulin resistance (IR) and vascular risk [2].
Thus far, the alarming growth of childhood obesity is leading to
a concomitant rise of the so-called ‘‘cardiometabolic syndrome’’
even in youth, explaining the relationship between higher BMI in
adolescence and greater disease risk in adulthood [3]. It is also
becoming clear that, as early as in childhood, obesity poses an
inflammatory environment both in the adipose tissue [4,5,6] and
in the circulation, as reflected by increased concentration of
inflammatory adipokines (ie, cytokines and chemokines) and
reduced levels of adiponectin, an insulin-sensitizing, anti-inflam-
matory adipose-derived mediator [7,8,9]. Adiponectin is also
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molecular weight (HMW) multimers being the most biologically
active [9]. Indeed, in obese adolescents, the impaired secretion of
the HMW oligomers, rather than deficiency of total adiponectin,
emerges as a stronger predictor of IR and incipient atherosclerosis
[10,11,12]. Moreover, circumstantial data in obese young children
suggest that elevated concentrations of ‘‘prototypical’’ inflamma-
tory cytokines (ie, IL-6 and TNF-a), adiponectin deficiency and
hyperleptinemia, which is also a sequel to chronic inflammation
[13], may coexist [7,14,15]. Altogether, these observations
strengthen the concept that the dysfunctional pattern of adipokines
in the bloodstream is initiated in, and sustained by, the ‘‘inflamed’’
fat [2]. However, the role of different adipose-derived mediators
(chemokines), individually or in combination, as independent
prediction markers of impaired glucose homeostasis and future
diabetes development in prepubertal age is still controversial
[8,16,17].
In this scenario, the characterization of a comprehensive profile
of adipokines in adolescence appears of considerable interest for
identification of ‘‘at-risk’’ individuals. Accordingly, in adults, the
joint effect of leptin and adiponectin, as ascertained by the leptin-
to-adiponectin ratio, has been proposed as a more reliable
predictor of IR and vascular risk than measurement of adiponectin
and leptin alone [18,19,20]. Since the enlarged/inflamed
adipocytes secrete more leptin and less adiponectin, especially
the HMW isomers [9], one may argue that the ratio of leptin-to-
HMW adiponectin (L/HMW) could serve as a useful indicator of
adipocyte dysfunction also before puberty begins.
As yet, in prepubertal childhood, the interrelations between
HMW adiponectin, leptin and different inflammatory adipokines,
as well as the effect modification by sex and adiposity have not
been ascertained in detail [11,21,22]. The overall aims of this
study were therefore to investigate sex differences and associations
of HMW adiponectin, leptin and proinflammatory adipokines
with adiposity and insulin resistance measures in prepubertal age.
To achieve this goal, we studied a cohort of prepubertal children
included in an extensive school-based survey, and characterized
the clinical phenotype, the endocrine and metabolic profile, as well
as a panel of adipokines/chemokines associated with adiposity and
glucose homeostasis. We postulated that, since gonadal steroids
may affect adiponectin oligomers distribution and circulating
leptin levels, partly explaining sex differences in association
between inflammatory markers and diabetes risk [23], a
dysregulated repertoire of these molecules in prepubertal age
would reflect the ‘‘quality’’ of individual adipose cells as well as
their association with insulin-resistance better than in adulthood
[4,11,21,22,24,25,26].
Methods
Participants
We studied 305 Italian children (boys/girls:144/161) aged 5–13
years, included in a cohort of 44,231 adolescents who participated
in an extensive school-based project on growth conducted in the
provinces of Perugia, Terni and Rieti of central Italy. The survey
design and methods have been previously described in detail
[27,28]. In the present study we enrolled only children who
fulfilled the following eligibility criteria: 1) prepubertal age (Tanner
stage 1); 2) absence of acute or chronic inflammatory illness; 3) lack
of diabetes mellitus, primary hyperlipidemia, hypertension and
obesity due to endocrine diseases; and, 4) no current regular
medications.
Written informed consent was obtained from the parents of the
children before their participation in the study, which has been
approved by the Ethics Committee of the Umbria Region and
carried out in accordance with the principles of the Helsinki
Declaration.
Anthropometric measurements
Anthropometric data included height, body weight, body mass
index (BMI), blood pressure, waist and hip circumferences, and
the waist-to-hip ratio (WHR) [27,28,29,30]. Body fat mass was
estimated by bioelectrical impedance analysis (BIA, Akern S.r.l,
Florence, Italy). Pubertal stage was classified according to Tanner,
whereas the standard deviation score of BMI (BMIz-score) was
calculated based on Cole’s method on central Italy L (lambda) M
(mu) S (sigma) reference values [28,31]. The LMS method
summarizes the distribution of BMI at each age in terms of three
smooth curves by its median (M), coefficient of variation (S) and
the Box-Cox power (L), required to transform raw data to a
standard normal distribution. Child overweight (OW) or obesity
(OB) were categorized according to age- and sex-specific
international cut-off points for BMI, identified for the percentiles
corresponding to BMIs of 25 (OW) and 30 (OB) kg/m
2 at 18
years, respectively [31]. Finally, systolic (SBP) and diastolic (DBP)
blood pressure values were standardized (Z-score) to the subjects’
sex, age and height, in order to provide a precise diagnostic
classification according to body size [32].
Biochemical analyses
Blood samples were collected during routine analysis, after
overnight fasting. Subjects were requested to maintain their usual
diet 8-10 days before testing. After separation, sera aliquots were
immediately stored at 270uC until analyzed. Follicle stimulating
hormone (FSH) and luteinizing hormone (LH) were determined by
immunoradiometric (IRMA) assay (CT Immunotec; Turin; Italy).
Total testosterone (DRG, Milan, Italy) and dehydroepiandroster-
one-sulphate (DHEA-S) (Radim, Rome, Italy) were assessed by
radioimmunoassay (RIA), while free-testosterone and estradiol
concentrations were evaluated by immunuoenzymatic assay
(DiaMetra, Milan, Italy). Fasting plasma insulin was measured
by RIA (Bouty, Cassina de’ Pecchi, Milan, Italy), with intra- and
inter-assay coefficients of variation (CV) ,10%. Homeostasis
model assessment of insulin resistance (HOMA-IR) was calculated
as follows: fasting insulin (mU/ml) 6 fasting glucose (mmol/l)/
22.5. Total adiponectin levels were analysed by RIA (Linco
Research, St. Charles, MO, USA). HMW adiponectin oligomers
were quantified by an enzyme-linked immunosorbent assay
(ELISA) from ALPCO Diagnostics (Salem, NH, USA), according
to the manufacturer’s instructions. Under our experimental
conditions, the intra- and inter-assay CV were both ,5%. Finally,
the serum concentration of leptin, interleukin (IL)-8, IL-18,
monocyte chemoattractant protein-1 (MCP-1), regulated on
activation, normal T-cell expressed and secreted (RANTES),
macrophage migration inhibitory factor (MIF), soluble intercellu-
lar adhesion molecule-1 (sICAM-1), interferon-c-inducible protein
10 (IP-10) and resistin were simultaneously measured by bead-
based multiplex assay using a Luminex 100 analyser (Luminex
Corporation, Austin, TX, USA), as described [1,14]. Fluorescent
xMAP COOH microspheres were purchased from Luminex.
Recombinant proteins were obtained from MBL (Nagoya, Japan;
IL-18), R&D Systems (Wiesbaden, Germany; MCP-1), the
National Institute for Biological Standards and Controls (Potters
Bar, UK; IL-8), and BD Biosciences (Heidelberg, Germany; IP-
10). Antibody pairs were purchased from MBL (IL-18), R&D
Systems (MCP-1, IL-8), and BD Biosciences (IP-10). Assay
characteristics for the measurement of leptin, IL-8, IL-18, MCP-
1, MIF, IP-10, resistin, RANTES and sICAM-1 were as follows:
Adipokines, Insulin Resistance and Adiposity
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21, 13, 20 and 16%, respectively; limits of detection, 9.8, 0.6, 0.6,
2.4, 4.9, 0.6, 2.4 pg/ml and 2.4 and 9.8 ng/ml, respectively. The
rationale behind the selection of this specific panel of inflammatory
molecules in our Luminex platform was that: 1) growing data
underscore the role of chemokines as modulators of macrophage
infiltration into adipose tissue and predictors of diabetes risk
[1,33,34,35]; and, 2) no prior study evaluated sex differences and
associations of these mediators with adiposity and IR measures in
prepubertal age.
Statistical analysis
Categorized comparisons for sex- and BMI-stratified groups
were analyzed by one-way ANOVA and Kruskal-Wallis test with
appropriate post-hoc corrections (Bonferroni’s, Tukey’s and
Kruskal-Wallis Z). Accordingly, for each response variable, the
main effects of sex and BMI, as well as their interaction, were
further ascertained by general linear models (factorial design).
Univariate correlations were assessed by Spearman rho (rs) and
partial correlation, while multivariate relationships were evaluated
using multiple regression models. The explanatory variables
entered the regression models according to the significance of
their correlation coefficients in bivariate analysis.
Before analysis, non-normally distributed data were appropri-
ately transformed (Box-Cox transformation) to better approximate
the Gaussian distribution (Kolmogorov-Smirnov test). Data are
shown as mean6SD or median (25
th;7 5
th percentile) for
parametric and non parametric variables, respectively. P-values
,0.05 were regarded as statistically significant. Statistical analysis
was performed using Predictive Analytic Software release 17.0.2
(SPSS Inc., Chicago, IL, USA).
Results
Subjects Characteristics
Participants’ characteristics are outlined in Table 1. When
compared with lean (L), OB children exhibited increased
abdominal fat distribution, higher fasting insulin, HOMA-IR
Table 1. Characteristics of the study population stratified by sex and BMI.
Boys Girls
Lean (L) Overweight (OW) Obese (OB) Lean (L) Overweight (OW) Obese (OB)
n. 59 32 70 46 28 70
Age (yrs) 9.2629 . 9 61.3
1 8.661.1 8.661.8 8.861.6 9.361.3
BMI (kg/m
2) 16.0 (15.1–17.6)
2 22.0 (20.9–22.7)
3 25.7 (24.5–27.6) 15.1 (14.2–16.2)
4 21.3 (19.5–22.7)
3 25.1 (23.8–26.8)
BMIz-score 20.4560.7
2 1.260.2
3 2.060.3 20.6460.8
4 1.260.2
5 2.160.4
Fat mass (kg) 5.3 (3.7–7.3)
2 10.8 (9.5–14.8)
3 18.0 (14.1–22.8) 4.4 (3.4–5.6)
4 12.3 (9.0–14.01)
3 15.7 (13.2–18.8)
Waist circumference (cm) 58.2 (53.2–61.0)
2 73.5 (68.2–76.0)
5 81.0 (76.0–87.3) 54.0 (51.2–57.5)
4 68.7 (66.6–74.5)
3 78.0 (73.0–82.0)
WHR 0.8560.04
6 0.8860.04 0.9260.07 0.8560.04
6 0.9160.15
7 0.8860.05
Fasting glucose (mmol/l) 4.560.5 4.460.5 4.460.4 4.260.6 4.360.4 4.460.4
Fasting insulin (pmol/l) 40.9 (28.7–56.7) 44.8 (37.5–58.8)
8 66.0 (50.2–89.0)
5 38.7 (21.5–52.2)
8 59.2 (43.1–103.0)
9 68.9 (52.4–97.6)
5
HOMA-IR 1.1 (0.8–1.7) 1.2 (1.0–1.5) 1.7 (1.3–2.3)
10 1.0 (0.5–1.5)
8 1.6 (1.2–1.4)
11 1.8 (1.4–2.6)
9
Total cholesterol (mmol/l) 4.2 (3.9–4.9) 4.4 (3.8–4.8) 4.1 (3.8–4.6) 4.6 (3.8–5.3) 4.2 (3.8–4.6) 4.2 (3.8–4.8)
HDL-C (mmol/l) 1.2 (1.0–1.3) 1.1 (1.0–1.5) 1.2 (0.9–1.4) 1.2 (1.1–1.4) 1.2 (1.0–1.4) 1.1 (0.9–1.3)
Triglycerides (mmol/l) 0.6 (0.5–0.8)
12 0.7 (0.5–0.8)
13 0.8 (0.6–1.1) 0.7 (0.6–0.8)
6 0.8 (0.5–1.1) 0.8 (0.7–1.3)
SBPz-score 20.07060.912 0.42660.922 0.15761.020 0.00160.882 0.13260.889 0.31760.987
DBPz-score 0.29560.672 0.35660.779 0.54760.712 0.24960.864 0.20660.751 0.35760.687
FSH (IU/L) 1.3 (0.6–2.0) 0.7 (0.6–1.6) 0.5 (0.1–1.0)
14 1.6 (0.6–2.5) 1.5 (0.7–2.9) 1.0 (0.4–2.5)
LH (IU/L) 0.2 (0.1–0.8)
11 0.3 (0.1–0.8) 0.1 (0.1; 0.4) 0.1 (0.1–0.2) 0.2 (0.1–0.5) 0.2 (0.2–0.3)
Total testosterone (nmol/l) 1.5 (0.7–1.7) 0.7 (0.6–1.6) 0.7 (0.7–1.0) 0.7 (0.7–1.0) 0.7 (0.7–1.3) 0.7 (0.7–1.0)
Free-testosterone (pmol/l) 2.2 (1.4–3.5) 2.1 (1.4–3.5) 2.4 (1.6–3.8) 2.4 (1.6–3.8) 3.1 (1.9–3.6) 2.4 (1.7–3.5)
Estradiol (pmol/l) NA NA NA 73.6632.6 72.9632.6 64.3631.4
DHEA-S (mmol/l) 1.0 (0.8–2.5) 1.8 (1.1–2.9) 1.6 (0.8–2.8) 0.9 (0.4–1.3)
7 0.9 (0.6–1.5) 1.3 (0.8–2.0)
1p,0.001 vs L and OB girls;
2p,0.0001 vs OW and OB boys and vs OW and OB girls;
3p,0.0001 vs L and OB boys and vs L and OB girls;
4p,0.0001 vs OW and OB girls and vs OW and OB boys;
5p,0.0001 vs L and OB boys and vs L girls;
6p,0.0001 vs OB within the gender;
7p,0.0001 vs OB girls and vs OW and OB boys;
8p,0.001 vs OW and OB girls and vs OB boys;
9p,0.0001 vs L boys and girls;
10p,0.0001 vs L and OW boys and vs L girls;
11p,0.05 vs L girls;
12p,0.001 vs OB boys and girls;
13p,0.0001 vs OB girls;
14p,0.0001 vs L boys and vs L, OW and OB girls; NA: not assessed.
doi:10.1371/journal.pone.0017264.t001
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from sex. Indeed, fasting insulin and HOMA-IR, which showed a
significant (p=0.01) sex-by-BMI-group interaction, were increas-
ing with adiposity in girls, whereas in boys the OW and the L
children displayed similar HOMA-IR values. Within either sex, no
significant group differences for blood pressure z-score or sex
steroids were found. OB girls, however, displayed higher FSH
concentrations, when compared with OB boys, and increased
DHEA-S levels, in comparison with L peers.
Adiponectin and leptin
In categorized comparisons across the groups, total and HMW
adiponectin showed a different sex distribution pattern (Figure 1,
panels A and B). In L children, while total adiponectin levels were
comparable in both sexes, the HMW multimers tended to be
higher in girls [3.9 (3.0; 5.0) mg/mL] than in boys [3.2 (2.1; 4.4)
mg/mL]. As compared with L peers, both OB and OW girls
exhibited similar total, but reduced (p,0.001) HMW adiponectin
concentrations. In boys, although OW and OB subjects displayed
HMW adiponectin levels similar to those of OW and OB girls,
respectively, the HMW forms did not differ across the BMI-
categorized groups. Moreover, total adiponectin concentrations
were increased (p,0.01) in OW as compared with OB boys.
In both sexes, leptin and L/HMW (Figure 1, panels C and D)
were increasingly higher with adiposity and differed significantly
(p,0.0001) between L and OW, L and OB, as well as OW and
OB individuals. Notably, neither leptin, nor adiponectin (total and
HMW) as well as the ratio L/HMW showed significant sex-by-
Figure 1. Box-whisker plots showing the levels of total and high molecular weight (HMW) adiponectin (panels A-B), leptin (panel C),
and the leptin-to-HMW adiponectin ratio (L/HMW) in the BMI-categorized groups, according to sex. Boxes represent median (line in the
middle of the boxes) and interquartile ranges (25
th and 75
th percentile; lines at the bottom and the top of the boxes, respectively). Error bars are 5
th
and 95
th percentiles. Differences between groups were analysed by Kruskal-Wallis test with Bonferroni’s post-hoc correction. L: lean; OW: overweight;
OB: obese;
"p=0.001 vs OB boys and OB girls;
#p,0.001 vs OW and OB girls and vs OB boys; *p,0.0001 vs OW and OB boys and vs OW and OB girls;
{p,0.0001 vs L and OB boys and vs L and OB girls;
{p,0.0001 vs L and OW boys and vs L girls; **p,0.0001 vs L and OW boys and girls;
1p,0.0001 vs
L girls and boys.
doi:10.1371/journal.pone.0017264.g001
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the response variable behaved the same when sex varied.
Overall, these data suggest that, while in L prepubertal children
HMW adiponectin may exhibit a tendency toward a sexual
dimorphism, leptin emerges as sex-independent discrimination
marker of adiposity degree.
Chemokine and Cytokine Concentrations
The concentrations of inflammatory chemokines and cytokines
are shown in Table 2. In girls, OB subjects presented higher
(p,0.05) IL-8, IL-18, MCP-1 and sICAM-1 levels, when compared
with L peers. In boys, only MIF concentrations were significantly
higher(p,0.05)inOBthaninOWcontrols(Table2).Noconsistent
group changes were seen for RANTES, IP-10 and resistin serum
levels. Interestingly, none of the above immune markers differed
significantly between sexes within the same BMI-stratified group,
and no consistent sex-by-BMI group interactions were seen.
Altogether, these data confirm the lack of a universal
upregulation of the immune response also in prepubertal obesity
[14], implicating that factors other than sex may modulate the
circulating levels of these mediators at this early age.
Adipokines, Adiposity and Insulin Resistance
In order to ascertain the interrelationships between HMW
adiponectin, leptin and inflammatory cytokines/chemokines,
individually or in combinations, with sex, adiposity or IR, we
performed correlation analyses and constructed multivariate
models in the combined study population and within each sex.
First, in both sexes, we found no significant association of leptin,
HMW adiponectin or inflammatory molecules with gonadal
steroids (supplementary Table S1). However, HMW adiponectin
(negatively), as well as both leptin and L/HMW (positively)
correlated with adiposity and IR measures, triglycerides and
sICAM-1 (supplementary Table S2). Interestingly, leptin and
HMW correlated in a reciprocal manner with each other and with
the inflammatory markers (supplementary Table S3). Also, the
inflammatory cytokines/chemokines displayed numerous positive
correlations with each other and with HOMA-IR (supplementary
Table S3). Adjustment for BMIz-score almost eliminated the
correlations of leptin and HMW adiponectin with the immune
mediators, whereas reciprocal associations between the inflamma-
tory markers with each other or IR measures remained partly
unaffected (supplementary Table S4). These data suggest that
adiposity explains, at least in part, the associations between HMW
adiponectin, leptin or the inflammatory mediators on the one
hand and impairment of glucose homeostasis on the other, while
correlations among immune markers appear obesity-independent.
Second, multivariate regression models were constructed to
predict HMW adiponectin levels (Table 3). As expected, fasting
insulin was a predictor of adiponectin multimers, explaining alone
about 5% of their variance (model 1). Adjustment for BMIz-score
(model 2) attenuated this interaction, which became insignificant
when lipids (models 3), or lipids, leptin and sICAM-1 entered the
model (model 4). In the full model (model 5), however, BMIz-score
was the strongest determinant of HMW adiponectin, and along
with triglycerides it accounted for additional 5% of its variance.
Moreover, in the prediction of HMW adiponectin, there were no
statistically significant interactions between sex and the explana-
tory variables (all interactions p.0.05) (data not shown).
Third, we explored whether leptin, HMW adiponectin or the
L/HMW might have explained the systemic IR as estimated by
HOMA-IR. In the combined study population (Table 4),
multivariate analysis indicated that each explanatory variable
alone (model 1) was a significant predictor of HOMA-IR, while
HMW adiponectin lost its significance after adjustments for age,
BMIz-score and lipids (model 2), or when sex and inflammatory
markers entered the regression model (model 3). In contrast, leptin
represented a strong and independent determinant of HOMA-IR.
However, we found statistically significant (p,0.05) interaction
between sex and leptin. Thus, multivariate analyses for HOMA-
IR were also stratified within each sex (Table 5). Of note, leptin
remained a strong and independent predictor of basal IR in girls,
while in boys its contribution became insignificant after adjust-
ments for age, BMIz-score and lipids (model 2), or when the
inflammatory markers entered in the model (model 3). Interest-
ingly, in all the models, the joint effect of L/HMW did not
improve the HOMA-IR prediction as compared with leptin alone,
and the inflammatory mediators did not meaningfully contribute
to changes in the outcome in a substantial way.
Finally, multivariate models indicated the BMIz-score as a strong
and independent determinant of leptin levels (Table 6), and, along
with HOMA-IR and triglycerides, it accounted for ,70% of its
Table 2. Cytokine and chemokine concentrations.
Boys Girls
Lean (L) Overweight (OW) Obese (OB) Lean (L) Overweight (OW) Obese (OB)
n. 59 32 70 46 28 70
IL-8 (pg/ml) 4.1 (1.9–7.7) 4.8 (2.7–7.0) 5.0 (2.5–10.4) 4.6 (2.7–6.3) 3.4 (2.3–5.3) 5.3 (3.6–9.9)
1
IL-18 (pg/ml) 241.3 (170.9–320.9) 188.4 (136.9–276.2) 200.1 (149.2–265.5) 182.6 (121.6–262.9) 178.1 (144.7–242.9) 240.6 (159.7–334.5)
1
MCP-1 (pg/ml) 688.7 (490.9–1058.9) 785.3 (611.7–987.9) 866.6 (601–1146.5) 543.7 (419.7–809.6) 781.1 (471.9–1038.4) 821.4 (677.7–1051.9)
1
RANTES (ng/ml) 138.6 (101.5–219.8) 143.1 (89.7–200.3) 166.8 (134.2–219.6) 132.3 (99.9–232.9) 163.7 (135.7–230.2) 185.1 (123.5–232.6)
MIF (pg/ml) 3756 (3221–4562) 3617 (3141–4043)
2 4190 (3525–4784)
3 3893 (3244–5047) 3927 (3484–4639) 4332 (3585–5046)
sICAM-1 (ng/ml) 32.1 (29.0–38.4) 30.9 (26.1–37.0) 33.2 (28.0–40.0) 31.6 (26.5–36.4) 33.2 (28.6–43.1) 34.2 (29.2–40.1)
1
IP-10 (pg/ml) 166.6 (131.7–259.1) 178.2 (130.9–241.1) 177.3 (145.8–221.2) 168.2 (125.9–245.0) 176.4 (129.5–276.6) 193.1 (159.2–256.3)
Resistin (pg/ml) 1701 (1276–1872) 1644 (1273–2017) 1728 (1412–2095) 1541 (1270–2140) 1539 (1320–2091) 1884 (1476–2168)
1p,0.05 vs L girls;
2p,0.05 vs OB girls;
3p,0.05 vs OW boys.
doi:10.1371/journal.pone.0017264.t002
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tions between sex and the explanatory variables associated with
leptin prediction (all interaction p.0.05). Accordingly, the
multivariable models stratified within each sex basically recapit-
ulated the results observed in the combined study population
(supplementary Tables S5 and S6).
Altogether, these findings circumstantiate the concept that, in
prepubertal age, adiposity may concur with altered lipid profile to
the impairment of HMW adiponectin, which appears partly
independent from low-grade inflammation. Finally, in this cohort
of prepubertal children, we found that leptin, at least in girls, was
an independent determinant of the basal insulin resistance, and,
independently from sex, it emerged as a stronger contributor of
HOMA-IR than HMW adiponectin.
Discussion
This study shows that, already in prepubertal age, obesity is
linked with hyperleptinemia, impaired HMW adiponectin levels,
as well as alterations of specific immune mediators with minor sex-
associated differences. Notably, in this very young population,
leptin, rather than HMW adiponectin, emerges as a sex-
independent discrimination marker of adiposity degree, as well
as a sex-related predictor of basal insulin resistance. Finally, also in
prepubertal obesity, we confirm the lack of a universal upregula-
tion of the immune response.
In obese children, persistent low-grade inflammation appears to
increase the metabolic risk in later life. The importance to
investigate adipose-derived mediators during the developmental
stages of overweight and obesity allows to identify at what age and
degree of adiposity these pathological events may occur. Our
current work describes the combined associations of obesity, IR
and sex on a cluster of adipokines in prepubertal children. The
characterization of a wide panel of adipose-derived mediators,
rather than measurement of single molecules only, appears of
considerable importance in youth since current conventional risk
factors may not be sensitive enough to detect high-risk individuals,
and the prognostic information provided may be different to those
in older obese subjects.
As yet, most of the studies on children analyzed a limited
number of adipose-produced mediators, and comparative analyses
for sex and pubertal stage were not always stratified over wide
BMI ranges [11,21,22,24]. Here we focused on prepubertal
children in their early phase of fat gain, making confounding
effects of co-morbidities or gonadal steroids unlikely. The first
main finding was that, independently from sex, hyperleptinemia
and, to a lesser extent, decreased HMW adiponectin, characterizes
prepubertal obesity.
Among the adipokines, adiponectin and leptin are unique
hormones because these pleiotropic mediators are almost
exclusively secreted by the adipocytes, and their systemic levels
reflect the degree of fat accrual in a reciprocal manner [9,16].
Adiponectin, however, circulates in low- (LMW), middle- (MMW)
and high-molecular weight (HMW) complexes, which exert
different biological functions [9]. In this regard, already in obese
Table 3. Multiple regression models for the prediction of the
high molecular weight adiponectin (HMW) (dependent
variable) in the combined study population.
Model
Independent
Variable(s) b p-value Model R
2
1 Fasting insulin 20.221 ,0.0001 0.049
2 Fasting insulin 20.142 0.037 0.068
BMIz-score 20.160 0.019
3 Fasting insulin 20.100 0.151 0.093
BMIz-score 20.128 0.063
Triglycerides 20.112 0.078
HDL 20.122 0.041
4 Fasting insulin 20.127 0.085 0.102
BMIz-score 20.230 0.017
Triglycerides 20.135 0.039
HDL 20.130 0.099
Leptin 0.159 0.121
sICAM-1 20.028 0.652
5 Fasting insulin 20.123 0.098 0.106
BMIz-score 20.225 0.027
Triglycerides 20.144 0.030
HDL 0.108 0.085
Leptin 0.152 0.180
sICAM-1 20.033 0.603
Age 0.012 0.867
Sex* 0.060 0.353
*Sex entered in regression model as ‘‘dummy’’ variable (0=girls; 1= boys).
b-coefficients, p-values and determination coefficients of regression models (R
2)
are given.
doi:10.1371/journal.pone.0017264.t003
Table 4. Multiple regression models for the prediction of the basal insulin resistance as ascertained by HOMA-IR (dependent
variable) in the total study population.
Independent variables
Model Leptin HMW L/HMW
b p-value Model R
2 b p-value Model R
2 b p-value Model R
2
1* 0.551 ,0.0001 0.304 20.206 0.001 0.04 0.548 ,0.0001 0.300
2
{ 0.326 ,0.0001 0.352 20.058 NS 0.323 0.306 ,0.0001 0.355
3
{ 0.291 ,0.01 0.378 20.055 NS 0.357 0.272 ,0.01 0.381
*Unadjusted model.
{Model adjusted for age, BMIz-score, triglycerides and HDL-Cholesterol.
{Additional adjustment for sex, sICAM-1, IL-8, MCP-1, RANTES, MIF and IP-10. Sex entered in regression model as ‘‘dummy’’ variable (0=girls; 1=boys). NS, statistically
not significant. b-coefficients and p-values for independent variables as well as determination coefficients of regression models (R
2) are given.
doi:10.1371/journal.pone.0017264.t004
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has been shown to reflect metabolic and vascular abnormalities
better than total adiponectin levels [10,11]. Prospectively, in
adults, hypoadiponectinemia, decreased HMW adiponectin and
increased leptin concentrations were differently reported as
independent predictors of T2D development and, less consistently,
of CHD events [8,9,13,26,36]. Notably, in our study, adiposity-
induced variations of leptin and, at least in female individuals,
changes of HMW adiponectin concentrations, were of the same
magnitude as those that predicted diabetes development in
adulthood, suggesting an early effect of these molecules on the
regulation of glucose homeostasis [8,13,18]. Thus, leptin upregu-
lation along with decreased HMW adiponectin subfractions may
both have a relevant impact for future disease risk in this subset of
obese, otherwise healthy, prepubertal children.
As long as at this age consistent effects of gonadal steroids
appear unlikely, different reasons may underlie the dysfunctional
profile of these adipokines. First, the lack of interconversion of the
adiponectin complexes in the bloodstream highlights the impor-
tance of the adipocyte secretory pathway in determining the
circulating pattern of adiponectin isoforms [9]. In adult males, we
have recently demonstrated that adipocyte enlargement and/or
IR, rather than body fat mass or testosterone, appear prerequisites
for the impaired cellular secretion of HMW adiponectin
complexes [37]. Accordingly, in prepubertal children, intracellular
content of adiponectin in subcutaneous adipocytes was reported to
be reduced with increasing BMIz-score [6]. Our findings partly
extend these results and implicate reduced HMW adiponectin and
increased leptin levels as early indicators of adipocyte enlargement
and cell dysfunction. The opposite associations between HMW
and leptin with adiposity measures, along with the observation that
BMIz-score was the strongest determinant of both leptin and HMW
multimers, partly support such a concept.
Second, since hyperinsulinemia or IR may either induce
hyperleptinemia or promote the selective downregulation of the
HMW adiponectin forms [9,38], a different degree of insulin
sensitivity in the adipose cells may well have contributed to the
impaired secretion of these adipokines. Accordingly, it has been
demonstrated that total adiponectin concentrations are more closely
related to variations in insulin-mediated glucose disposal than to fat
mass expansion [39]. In our study, we showed that the associations of
Table 5. Multiple regression models for the prediction of the basal insulin resistance as ascertained by HOMA-IR (dependent
variable) in boys and girls.
Boys
Independent variables
Leptin HMW L/HMW
Model b p-value Model R
2 b p-value Model R
2 b p-value Model R
2
1* 0.471 ,0.0001 0.222 20.124 NS 0.015 0.465 ,0.0001 0.217
2
{ 0.193 NS 0.264 20.04 NS 0.256 0.204 NS 0.269
3
{ 0.167 NS 0.308 20.057 NS 0.303 0.196 NS 0.314
Girls
Independent variables
Leptin HMW L/HMW
Model b p-value Model R
2 b p-value Model R
2 b p-value Model R
2
1* 0.627 ,0.0001 0.393 20.265 ,0.01 0.070 0.606 ,0.0001 0.368
2
{ 0.49 ,0.0001 0.454 20.058 NS 0.392 0.351 ,0.01 0.434
3
{ 0.415 ,0.01 0.513 20.044 NS 0.47 0.304 ,0.01 0.500
*Unadjusted model.
{Model adjusted for age, BMIz-score, triglycerides and HDL-Cholesterol.
{Additional adjustment for sICAM-1, IL-8, MCP-1, RANTES, MIF and IP-10. NS, statistically not significant. b-coefficients and p-values for independent variables as well as
determination coefficients of regression models (R
2) are given.
doi:10.1371/journal.pone.0017264.t005
Table 6. Multiple regression models for the prediction of
leptin (dependent variable) in the combined study
population.
Model
Independent
variable(s) b p-value Model R
2
1 BMIz-score 0.779 ,0.0001 0.606
2 BMIz-score 0.636 ,0.0001 0.667
HOMA-IR 0.192 ,0.0001
Triglycerides 0.160 ,0.0001
LDL 20.045 NS
3 BMIz-score 0.641 ,0.0001 0.671
HOMA-IR 0.194 ,0.0001
Triglycerides 0.153 ,0.0001
LDL 20.044 NS
HMW 0.054 NS
MCP-1 0.003 NS
RANTES 0.054 NS
MIF 20.035 NS
Sex* 20.071 0.051
*Sex entered in regression model as ‘‘dummy’’ variable (0=girls; 1= boys). NS,
statistically not significant; b-coefficients, p-values and determination
coefficients of regression models (R
2) are given.
doi:10.1371/journal.pone.0017264.t006
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S4) with HMW adiponectin were attenuated or became insignificant
after adjustments for BMIz-score or lipids, respectively. Thus, the
association of HMWadiponectin with IR appears partlymediated by
adiposity. In contrast, leptin, which was also largely explained by
adiposity (Table 6), represented an independent and stronger
predictor of the systemic IR as compared with HMW or the
combinational effect of L/HMW (Table 4). The demonstration that
in adipocytes adiponectin and leptin are secreted through distinct
trafficking pathways [41], which appear modulated by insulin in
different ways [38], may partly explain these findings, substantiating
the hypothesis that derangements of glucose homeostasis develop at
an early preclinical stage as a result of adipocyte dysfunction/
enlargement [5,6]. On the other hand, it has recently been postulated
that, in obese prepubertal children, HMW adiponectin shows closer
relationship with improvement of glucose homeostasis after weight
loss, rather than with body fat content [42]. Nonetheless, we have
previously demonstrated that, in obese children and adolescents, the
degree of hyperleptinemia was a reliable predictor of responsiveness
to an educational program of weight excess reduction [29,30]. It
seems thus plausible that, in prepubertal age, leptin may provide
prognostic information (ie, prediction of weight-excess reduction)
different to that of HMW adiponectin (ie, improvement of glucose
homeostasis after weight loss).
Third, although HMW adiponectin, leptin and inflammatory
markers appear to some extent interdependent, the addition of
leptin and sICAM-1 as ‘‘inflammation-related’’ confounders did
not improve the prediction of HMW adiponectin, fostering the
concept that, although mutually antagonistic, low-grade inflam-
mation and HMW adiponectin may reflect two distinct features of
the immune response, as previously postulated [43].
In adolescents, various and controversial studies addressed
the sex-associated variability of total adiponectin and leptin
[11,21,22,24,25], while information on HMW is scarce. In our
cohort, when BMI-categorized groups were analyzed, a tendency
toward a sex-dimorphic pattern for HMW adiponectin in lean
individuals was found, whereas leptin allowed a sex-independent
discrimination of adiposity degree. However, for both leptin and
HMW adiponectin we did not find significant sex-by-BMI-group
interaction, implicating the lack of consistent changes of the
response variable when, at the sameBMI category, sex varied. Even
more, sex did not affect the prediction of BMIz-score on HMW
adiponectin (Table 3) and leptin (supplementary Tables S5 and S6).
Hitherto, although two population-based surveys found higher total
adiponectin levels in girls than in boys even in prepubertal age,
consistent with our results other authors did not [21,24,25]. These
discrepancies may largely reflect the lack of comparisons across
differentially categorized groups. Here, we adopted Cole’s criteria
[31] and incorporated a broad spectrum of clinical phenotypes,
making thus the occurrence of group misclassification unlikely. It is
conceivable, and remains to be shown, that inherent characteristics
of adipocyte cellular function as well as variations in molecular
degradation or clearance rate may influence the levels of these
mediators in lean prepubertal children [9].
On the other hand, sex represented an ‘‘effect modifier’’ in the
interaction between leptin and basal IR. Our observation that
leptin was an independent determinant of HOMA-IR in girls, but
not in boys (Table 5), is however in line with the notion that, in
adulthood, inflammation appears more strongly associated with IR
and diabetes risk in females than in males [23,40]. As far as in our
study sex differences regarding body composition and systemic
gonadal steroids levels (ie, testosterone) were not apparent, such
sex-associated differences may have several explanations. Different
degrees of adjustment in the multivariable models (ie, larger sex-
differences according to the number of confounders) as well as
chance (reduced sample size) might both have played a role.
Moreover, although we can reasonably exclude the effect of
ethnicity, the influence of different baseline risk factors of IR
cannot be ruled out.
Turning to the other major finding of this study, childhood
obesity is not characterized by a generalized immune activation, but
rather a differential upregulation of specific chemokines/cytokines
with minor sex differences [14]. Obese girls, indeed, displayed
higher IL-8, IL-18, MCP-1 and sICAM-1 levels, while in boys
adipositywaslinked with increased MIF concentrations. The lack of
consistent sex-by-BMI-group interaction, as well as the absence of
significant correlations between gonadal steroids and all of the
above immune mediators (supplementary Table S1), reasonably
indicates that factors other than sex (ie., nutritional habits, physical
activity) may partly explain these differences. Although no prior
study has evaluated such a specific repertoire of adipokines in
prepubertal age, our data are of interest because these chemokines
represent crucial immune mediators involved in macrophage
infiltration into adipose tissue, which reasonably occurred also in
our cohort of obese children [5]. Moreover, as far as elevated
concentrations of IL-8, MCP-1, IL-18 and MIF may precede the
onset of T2D in adults [1,33,34,35], our data indicate that, in
prepubertal age, the association between these immune mediators
and HOMA-IR appears basically explained by adiposity (supple-
mentary Tables S3 and S4). Accordingly, in multivariate analysis,
the inflammatory markers did neither affect the ability of leptin in
predicting basal IR nor contributed significantly to variations in
HOMA-IR (Table 4). On the other hand, the observation that the
immune markers correlated directly with each other, also
independently from individual’s BMI (supplementary Table S4),
suggests that sources other than fat tissue may contribute to the
elevated circulating levels of these chemokines.
Study limitations and Strengths
This study has some limitations that need to be considered. The
cross-sectional nature of the survey does not allow conclusions to
be drawn about the true prognostic values and the molecular
mechanisms underlying the relationships between adipokines and
IR. In addition, since in prepubertal age overweight and obesity
may not necessarily track into adulthood, the prognostic relevance
of these results should be further ascertained. However, obesity-
linked variations of adipokines levels we found were almost
comparable to those that predicted the risk of diabetes in adults
[8,13,18], and the prognostic role of leptin also as a predictor of
weight excess reduction was earlier demonstrated [29,30].
Moreover, we did not characterize the middle- and low-molecular
weight adiponectin oligomers, which may also have a differential
distribution according to adiposity degree. On the other hand, the
HMW multimers appear the major active forms in mediating the
metabolic effects of adiponectin even in young children [9,10,11].
These constraints have to be weighed against the strengths of
our survey which reside in the sample size, the representative
nature of the population studied, the extensive characterization of
the study participants, the simultaneous determination of multiple
adipokines as well as the careful adjustment for various
confounders using multivariable methods.
Conclusions and Perspectives
In conclusion, our findings demonstrate that, as early as in
prepubertal age, adiposity exhibits an unfavourable pattern of
adipokines with minor sex-associated differences. However,
among the adipose-derived mediators, leptin can be envisioned
as a sex-independent discrimination marker of adiposity degree
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resistance as estimated by HOMA-IR. Therefore, in prepubertal
children, hyperleptinemia may allow the early identification of ‘‘at-
risk’’ individuals, providing important prognostic information in
predicting the impairment of glucose homeostasis.
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